Centrum Słuchu i Mowy MEDINCUS

What Centrum Słuchu i Mowy MEDINCUS does

Centrum Słuchu i Mowy MEDINCUS is a Polish private healthcare network (Centrum Słuchu i Mowy sp. z o.o.) specializing in the diagnosis, surgical treatment, and rehabilitation of hearing, speech, voice, and balance disorders. Founded in 2002 and headquartered in Kajetany near Warsaw, the network operates 18 medical facilities across Poland, a flagship dedicated hospital — the International Hearing and Speech Center MEDINCUS — in Kajetany, seven dedicated hearing-aid retail showrooms under the MEDINCUS Aparaty Słuchowe sub-brand, and seven international branches in Senegal, Kyrgyzstan, Kazakhstan, and Ukraine. The company reports 150,000 consultations and 2,500 surgical procedures annually.

The clinical portfolio spans otolaryngology, audiology, and phoniatrics, with vertically integrated implant services covering cochlear, middle-ear, and bone-conduction devices from all four major manufacturers (Advanced Bionics, Cochlear, MED-EL, Oticon Medical). MEDINCUS also offers proprietary therapeutic modalities including the SPPS-S method (Stimulation of Polymodal Sensory Perception, developed by Prof. Piotr H. Skarżyński), transcutaneous vagus nerve stimulation (tVNS), and the Lenire bimodal neuromodulation device for tinnitus. An AI-supported diagnostic stack — automated ABR/audiometry analysis, EEG cortical auditory evoked potential interpretation, and the Hear Box adaptive screening system — is being developed under six EU-subsidized R&D projects.

The business model is hybrid: clinical services, implant surgery, and rehabilitation are reimbursed via Polish National Health Fund (NFZ) contracts and private pay; hearing aids and ear-mold prosthetics are sold through the dedicated retail showrooms; and a clinical-trials business unit generates contract research revenue. Customer acquisition runs through an online e-registration portal, dedicated phone hotlines (including a specialized line for profound hearing-loss patients), GP/pediatrician referrals, content marketing, and participation in international conferences (notably as key partner of CI 2026). The company is privately held with no institutional investors or public shareholders identified, and has historically relied on EU grant co-funding rather than equity capital for R&D scaling.

Name

Centrum Słuchu i Mowy MEDINCUS

Legal name

Centrum Słuchu i Mowy sp. z o.o.

Website

https://medincus.pl

Company type

Private

Operating status

Operating

Headcount range

101–250 employees

Short description

Centrum Słuchu i Mowy MEDINCUS is a privately held Polish specialty healthcare network providing vertically integrated diagnosis, surgery, and rehabilitation for hearing and speech disorders through 18 Polish facilities, a flagship hospital in Kajetany, and seven international branches.

Ownership category

akta.pro rank

Product category

Hearing and Speech Healthcare Services

NAICS

Offices of Physical, Occupational and Speech Therapists, and Audiologists (621340), Offices of Other Health Practitioners (6213)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Audiology & Hearing Services (ENT-Affiliated) (HLAKAMAI)

akta.pro secondary industries

Otology & Neurotology (Ear/Hearing/Balance) (HLAKAMAC), Audiology & Hearing Diagnostic Centers (HLAFAKAH)

Keywords

• Audiology services
• Hearing implant surgery
• Speech therapy
• Otolaryngology care
• Tinnitus treatment

Headquarters

HQ city

Kajetany (Nadarzyn)

HQ country

Poland

HQ region

Europe

Offices32 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Medical Healthcare Services: Comprehensive healthcare services including consultations, diagnostics, surgical procedures, and rehabilitation for hearing and speech disorders. Revenue generated through National Health Fund (NFZ) public insurance contracts and private patient payments.
2. Hearing Aids and Prosthetics: Sale and fitting of hearing aids, ear molds, and related prosthetic devices through dedicated MEDINCUS Hearing Aids facilities.
3. Hearing Implant Surgery and Rehabilitation: Full-service cochlear, middle ear, and bone conduction implant procedures including diagnostics, surgery, and post-operative rehabilitation.
4. Clinical Research Services: Conducting clinical trials as part of international research projects, contributing to development of innovative diagnostic and therapeutic solutions.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Core offering

Centrum Słuchu i Mowy MEDINCUS is a specialized healthcare network providing comprehensive diagnosis, treatment, surgery, and rehabilitation services for hearing and speech disorders. Its core offerings include hearing implant procedures (cochlear, middle ear, bone conduction), hearing aid fitting, tinnitus therapy (Lenire device), vagus nerve stimulation (tVNS), and the proprietary SPPS-S therapy for central auditory processing disorders. Services are delivered across 18 facilities in Poland and 7 international branches, accessible via NFZ public insurance and private payment.

Product overview

Centrum Słuchu i Mowy MEDINCUS operates as a network of specialized medical facilities providing comprehensive hearing and speech healthcare services. The portfolio includes: (1) Core clinical services encompassing otolaryngology, audiology, and phoniatrics with associated surgical procedures; (2) Hearing implant services covering cochlear implants, middle ear implants, and bone conduction implants from all major manufacturers (Advanced Bionics, Cochlear, MED-EL, Oticon); (3) Hearing aids and prosthetics services; (4) Proprietary SPPS-S therapy and tVNS vagus nerve stimulation for neurological-auditory conditions; (5) Lenire bimodal neuromodulation device for tinnitus; (6) Digital platforms including e-Rejestracja for patient registration, Hear Box adaptive screening system, and SPPS-S Home AI-powered therapeutic platform for home-based CAPD therapy. The organization also provides rehabilitation services including speech therapy, psychological therapy, pedagogical therapy, and hearing/speech rehabilitation across 18 facilities in Poland and 7 international branches.

Differentiator

Problem solved

Functional benefit

Brands

• Hear Box: Adaptive hearing screening-diagnostic system for self-administered hearing tests in rooms with varying acoustics, using automated hearing threshold detection algorithms and active noise reduction.
• SPPS-S Home

Products and services

• Hearing Implant Diagnostics, Surgery and Rehabilitation Comprehensive cochlear implant, middle ear implant, and bone conduction implant services including full diagnostic evaluation, surgical procedures, and post-operative rehabilitation with psychoacoustic evaluation and custom fitting. Covers devices from all major manufacturers (Advanced Bionics, Cochlear, MED-EL, Oticon Medical).
• Hearing Aids and Hearing Care (Protetyka Słuchu) Professional hearing aid fitting, selection, and ongoing hearing care services including ear mold customization, delivered through dedicated MEDINCUS Aparaty Słuchowe facilities.
• SPPS-S (Stimulation of Polymodal Sensory Perception) Therapy Proprietary therapy method developed by Prof. Skarżyński for stimulating polymodal sensory perception, used for diagnosis and therapy of central auditory processing disorders.
• tVNS Therapy (Transcutaneous Vagus Nerve Stimulation) Non-invasive transcutaneous vagus nerve stimulation therapy for neurological and auditory conditions.
• Lenire Tinnitus Treatment Device Therapy Bimodal neuromodulation device therapy for tinnitus combining sound and tongue stimulation.
• MED-EL Service Center Official MED-EL service representative providing warranty and post-warranty maintenance, spare parts, replacement processor rentals during repairs, and new solution presentations.
• Telefitting Speech Processor Settings Remote fitting and programming services for speech processors for hearing implant users.
• e-Rejestracja Online Patient Registration Electronic patient registration system for self-service scheduling of appointments across all MEDINCUS facilities.

Quantifiable outcome

• 150,000 consultations annually
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

Partnerships

Five partnerships are on record, tiered core.

• Instytut Fizjologii i Patologii Słuchu (Institute of Physiology and Pathology of Hearing)coreStrategic or Co-development Partner · 1 January 2020Consortium partner with MEDINCUS as project leader on the Hear Box adaptive screening-diagnostic system project (POIR.01.01.01). The Institute collaborates on research and development of innovative hearing diagnostic and therapeutic solutions.
• Advanced BionicscoreTechnology or IntegrationHearing implant manufacturer whose devices are used at MEDINCUS facilities. The organization offers devices from all major manufacturers: Advanced Bionics, Cochlear, MED-EL, and Oticon Medical.
• CochlearcoreTechnology or IntegrationHearing implant manufacturer whose devices are used at MEDINCUS facilities, including the Cochlear OSIA bone conduction implant (first in Poland implanted at MEDINCUS in December 2024).
• MED-ELcoreTechnology or IntegrationHearing implant manufacturer. MEDINCUS operates as official MED-EL service representative, providing warranty and post-warranty service, spare parts, and processor rental for MED-EL implant users.
• Oticon MedicalcoreTechnology or IntegrationHearing implant manufacturer whose SENTIO implant was first implanted in Poland at MEDINCUS in December 2024 for an adult patient.

Scale indicators12 records

Recent moves5 records

Expansion highlights6 records

Emerging players

• Hear.com: D2C hearing aid platform with telehealth audiology services across multiple countries. Comparable to MEDINCUS as an audiology services provider targeting hearing loss patients, though focused on device sales via telemedicine rather than surgical implants.

Broad incumbents

• Amplifon: Global hearing care retail and clinical services leader with thousands of points of sale across Europe and beyond. Directly comparable to MEDINCUS as a multi-site hearing care network, though more retail-focused and less specialized in surgical hearing implants.
• Sonova: Hearing care conglomerate owning Phonak, Advanced Bionics, and Unitron. Comparable to MEDINCUS as both a hearing aid provider and implant manufacturer partner; broader portfolio but does not run specialty surgical hospitals directly.
• WS Audiology: Hearing aid manufacturer (Signia, Widex) with retail presence. Comparable as a multi-brand hearing care provider in Europe, although less specialized in surgical and speech therapy services than MEDINCUS.
• Starkey Hearing Technologies: US-based hearing aid manufacturer with global clinical and retail partnerships. Comparable to MEDINCUS as a hearing device maker intersecting the audiology clinic market, though primarily device-focused without hospital operations.
• Demant: Owner of Oticon, Bernafon, Sonic, and Oticon Medical (hearing implants). Comparable as a parent of a major implant brand (Oticon Medical) whose SENTIO device was first implanted in Poland at MEDINCUS, and as a broader hearing care incumbent.

Regional players

• Kind Hörgeräte: German specialty hearing care chain offering hearing aids, audiology services, and pediatric audiology. Comparable to MEDINCUS as a multi-site audiology-focused European provider; less specialized in surgical implants and speech therapy.
• Audika Group: European hearing care network with retail and clinical audiology services, primarily in France and broader Europe. Comparable to MEDINCUS as a multi-site audiology provider, though more retail-oriented and with weaker implant/surgical capabilities.

Direct peers

• Cochlear Limited: World-leading cochlear implant manufacturer and a core technology partner of MEDINCUS. Comparable because MEDINCUS performs Cochlear implant surgeries (including first-in-Poland OSIA) and is part of Cochlear's clinical delivery network globally.
• MED-EL: Major hearing implant manufacturer with which MEDINCUS operates as official service representative. Comparable as a cochlear and middle-ear implant partner whose devices are surgically implanted at MEDINCUS's Kajetany hospital.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/CentrumSluchuiMowy
• LinkedInlinkedin.com/company/centrum-s%C5%82uchu-i-mowy-medincus

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centrum Słuchu i Mowy MEDINCUS